Added 2 days ago Drug news

FDA approves Xenleta to treat community-acquired bacterial pneumonia - Nabriva Therapeutics

Nabriva Therapeutics plc announced that the FDA has approved Nabriva’s new drug applications for the oral and intravenous (IV) formulations...

Added 1 month ago Drug news

Motif Bio submits a meeting request to the FDA concerning its iclaprim application to treat ABSSSI.

Motif Bio plc , announced that it has submitted a meeting request and package to the FDA related to the...

Added 1 month ago Drug news

ARIES MRSA Assay filed with the FDA for infectious disease detection

Luminex Corporation announced that the company submitted the ARIES MRSA Assay to the FDA for clearance on Friday, June 28,...

Surgical site infections: prevention and treatment

This guideline covers preventing and treating surgical site infections in adults, young people and children who are having a surgical procedure involving a cut through the skin.

Added 10 years ago

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 3 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 7 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 1 year ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 2 years ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 2 years ago